Kodiak Sciences Inc (KOD)
3.07
-0.04
(-1.29%)
USD |
NASDAQ |
May 24, 16:00
3.07
0.00 (0.00%)
After-Hours: 20:00
Kodiak Sciences Total Liabilities (Quarterly): 193.57M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 193.57M |
December 31, 2023 | 213.59M |
September 30, 2023 | 245.24M |
June 30, 2023 | 251.18M |
March 31, 2023 | 247.75M |
December 31, 2022 | 230.46M |
September 30, 2022 | 244.46M |
June 30, 2022 | 250.97M |
March 31, 2022 | 252.90M |
December 31, 2021 | 240.90M |
September 30, 2021 | 231.89M |
June 30, 2021 | 218.17M |
March 31, 2021 | 211.06M |
Date | Value |
---|---|
December 31, 2020 | 206.60M |
September 30, 2020 | 198.96M |
June 30, 2020 | 120.17M |
March 31, 2020 | 115.36M |
December 31, 2019 | 13.51M |
September 30, 2019 | 9.225M |
June 30, 2019 | 8.256M |
March 31, 2019 | 6.982M |
December 31, 2018 | 5.356M |
September 30, 2018 | 110.94M |
June 30, 2018 | 5.046M |
December 31, 2017 | 71.98M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.256M
Minimum
Jun 2019
252.90M
Maximum
Mar 2022
185.21M
Average
215.88M
Median
Total Liabilities (Quarterly) Benchmarks
Avalo Therapeutics Inc | 224.81M |
Regeneron Pharmaceuticals Inc | 7.378B |
Ligand Pharmaceuticals Inc | 107.35M |
iBio Inc | 25.29M |
Dare Bioscience Inc | 24.01M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 434.76M |
Shareholders Equity (Quarterly) | 241.19M |